Incretin-based therapies for the treatment of obesity-related diseases US$ 25.78 Min. order: 1 piece ★★★★★ 4.9 (17 reviews) Sold : Login>>
The evolving landscape of obesity pharmacotherapy US$ 24.38 Min. order: 1 piece ★★★★★ 4.9 (156 reviews) Sold : Login>>
Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity US$ 23.20 Min. order: 1 piece ★★★★★ 5.0 (68 reviews) Sold : Login>>
Full article: Pharmacotherapy for Obesity: Recent Updates US$ 20.68 Min. order: 1 piece ★★★★★ 5.0 (197 reviews) Sold : Login>>
Mazdutide and Tirzepatide: How These Dual-Pathway Weight-Loss Drugs Really Compare US$ 23.39 Min. order: 1 piece ★★★★★ 4.3 (83 reviews) Sold : Login>>